Ache Laboratorios Farmaceuticos S.a.

This Phase 3 trial tests a new eye drop, DNN.31.19.026, against a standard treatment (Cosopt) for people with high eye pressure or open-angle glaucoma. About 336 adults will use the drops twice daily for 56 days. The main goal is to see if the new drop lowers eye pressure better …

This study tests a new medicine, DNN.65.21.005, against a standard drug (Combodart) to see if it safely reduces urinary problems caused by an enlarged prostate. About 218 men aged 50 and older with bothersome symptoms will take the drug for 180 days. The main goal is to measure c…